| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 08/12/2009 | CN101505740A Improved method of treatment of bacterial infections |
| 08/12/2009 | CN101505739A Methods for the production of functional protein from DNA having a nonsense mutation and the treatment of disorders associated therewith |
| 08/12/2009 | CN101505738A Chewable tablet containing phenylephrine |
| 08/12/2009 | CN101505736A Controlled release system and method for manufacturing the same |
| 08/12/2009 | CN101505735A Pharmaceutical compositions for sustained release of phenyephrine |
| 08/12/2009 | CN101505733A Active agent formulations, methods of making, and methods of use |
| 08/12/2009 | CN101505732A Low dose sublingual tablets of opioid analgesics and preparation process |
| 08/12/2009 | CN101505731A Compositions comprising calcium citrate malate and methods for making the same |
| 08/12/2009 | CN101505730A Compositions comprising calcium citrate malate and methods for making the same |
| 08/12/2009 | CN101505728A Aerosol formulation containing beta agonists and steroids |
| 08/12/2009 | CN101505727A Pharmaceutical composition for oral administration |
| 08/12/2009 | CN101505726A Pharmaceutical suspensions comprising phenylephrine and method of preparation |
| 08/12/2009 | CN101505724A Galenic formulations of aliskiren |
| 08/12/2009 | CN101505603A Boron-containing small molecules |
| 08/12/2009 | CN101505599A 5(S)-(2'-hydroxyethoxy)-20(S)-camptothecin and its preparation and use for the treatment of cancer |
| 08/12/2009 | CN101505598A Sigma ligands for neuronal regeneration and functional recovery |
| 08/12/2009 | CN101505595A IL-8 receptor antagonist |
| 08/12/2009 | CN101505594A Combination treatment for metabolic disorders |
| 08/12/2009 | CN101503736A Use of retinoic acid induced gene I, signal pathway mediated by coding protein thereof |
| 08/12/2009 | CN101503722A Biological polysaccharide, and production and use thereof |
| 08/12/2009 | CN101503456A Cynoglossum extract, preparation and use thereof |
| 08/12/2009 | CN101503454A Compound for preparing cholic acid conjugate, preparation and use thereof |
| 08/12/2009 | CN101503453A Nucleic acid molecule CRYL1SI3 and use thereof in anti-cancer medicine preparation |
| 08/12/2009 | CN101503452A Nucleic acid molecule CRYL1SI32 and use thereof in anti-cancer medicine preparation |
| 08/12/2009 | CN101503451A Nucleic acid molecule CXSI2 and use thereof in anti-cancer medicine preparation |
| 08/12/2009 | CN101503450A Nucleic acid molecule CXSI3 and use thereof in anti-cancer medicine preparation |
| 08/12/2009 | CN101503449A Nucleic acid molecule CXSI32 and use thereof in anti-cancer medicine preparation |
| 08/12/2009 | CN101503448A Nucleic acid molecule CXSI22 and use thereof in anti-cancer medicine preparation |
| 08/12/2009 | CN101503447A Nucleic acid molecule CXSI2 and use thereof in anti-cancer medicine preparation |
| 08/12/2009 | CN101503446A Nucleic acid molecule CXSI1 and use thereof in anti-cancer medicine preparation |
| 08/12/2009 | CN101503445A Nucleic acid molecule SI-CYPJ-32 and use thereof in anti-cancer medicine preparation |
| 08/12/2009 | CN101503444A Nucleic acid molecule SI-CYPJ-3 and use thereof in anti-cancer medicine preparation |
| 08/12/2009 | CN101503443A Nucleic acid molecule SI-CYPJ-22 and use thereof in anti-cancer medicine preparation |
| 08/12/2009 | CN101503442A Nucleic acid molecule SI-CYPJ-2 and use thereof in anti-cancer medicine preparation |
| 08/12/2009 | CN101503441A Nucleic acid molecule SI-CYPJ-1 and use thereof in anti-cancer medicine preparation |
| 08/12/2009 | CN101503440A Nucleic acid molecule SI-CYPJ-12 and use thereof in anti-cancer medicine preparation |
| 08/12/2009 | CN101503439A Nucleic acid molecule SI-CYPJ-52 and use thereof in anti-cancer medicine preparation |
| 08/12/2009 | CN101503438A Nucleic acid molecule SI-CYPJ-5 and use thereof in anti-cancer medicine preparation |
| 08/12/2009 | CN101503437A Nucleic acid molecule SI-CYPJ-4 and use thereof in anti-cancer medicine preparation |
| 08/12/2009 | CN101503436A Nucleic acid molecule SI-CYPJ-42 and use thereof in anti-cancer medicine preparation |
| 08/12/2009 | CN101503423A Parachlorobenzoyl hydrazone organotin complex, preparation and use |
| 08/12/2009 | CN101503414A Thiazolo[3,2-b]-1,2,4-triazine derivative and use thereof |
| 08/12/2009 | CN101503407A Imidazopyridine compound |
| 08/12/2009 | CN101503402A 2-aniline pyrimidine derivative, as well as preparation and uses thereof |
| 08/12/2009 | CN101503399A C-aryl glucoside SGLT2 inhibitor |
| 08/12/2009 | CN101503397A Halogenated furan ketone compound, and use thereof in antiinfective drug preparation |
| 08/12/2009 | CN101503394A High piperazine acetydrazide derivatives, and preparation and use thereof |
| 08/12/2009 | CN101503392A Aromatic aminomethane compounds, as well as preparation and medical use thereof |
| 08/12/2009 | CN101502697A Sanitary moisture paper tissue and preparation method thereof |
| 08/12/2009 | CN101502674A Medical device with coating that promotes endothelial cell adherence and differentiation |
| 08/12/2009 | CN101502668A Polyphenol-protein complexes and method for producing the same, patch containing the polyphenol-protein complexes and method for producing the same |
| 08/12/2009 | CN101502660A Medicine-carrying polylactic acid microcapsular ultrasound contrast agent and preparation method thereof |
| 08/12/2009 | CN101502656A Composition for eliminating bitter taste of soluble and stable macrolides medicament |
| 08/12/2009 | CN101502654A Preparation method of high-gloss high-stability Elsinochrome silicon oxide nano granule and application thereof in preparing intravenous injection agent |
| 08/12/2009 | CN101502653A Medicament composition for preventing or treating Streptococcus suis disease |
| 08/12/2009 | CN101502649A Liposome influenza vaccine |
| 08/12/2009 | CN101502646A Preparation for female body shaping and gynaecological inflammation and method for producing the same |
| 08/12/2009 | CN101502645A Compound medicament for treating malignant pleuroperitoneal cavity dropsy and use thereof |
| 08/12/2009 | CN101502636A Pure medicinal formulation for treating cancer and preparation method thereof |
| 08/12/2009 | CN101502635A Medicament composition containing Reserpine |
| 08/12/2009 | CN101502631A Synergistic medicament composition containing Aolamite and Chinese medicine extract |
| 08/12/2009 | CN101502625A Chinese medicine for treating women's postpartum syndrome and preparation method thereof |
| 08/12/2009 | CN101502615A Plaster for traumatic injury and bone fracture |
| 08/12/2009 | CN101502611A Medicament for treating cancer and preparation method thereof |
| 08/12/2009 | CN101502608A Chinese paris rhizome total sapogenin oral medication preparation as well as preparation method and application thereof |
| 08/12/2009 | CN101502595A Chinese medicine for treating periodontitis and preparation method thereof |
| 08/12/2009 | CN101502593A Compound formulation of washing lotion for treating beriberi and dermatophytosis |
| 08/12/2009 | CN101502591A Pharmaceutical composition for reducing blood sugar and blood fat |
| 08/12/2009 | CN101502590A Pharmaceutical composition for reducing blood sugar and blood fat |
| 08/12/2009 | CN101502589A Chinese and western medicinal composition containing bifendate for auxiliary treatment of hepatitis |
| 08/12/2009 | CN101502572A Auxiliary Chinese and western medicinal composition for treating hepatitis |
| 08/12/2009 | CN101502569A Sanitary hydrojet for cleaning vagina and preparation method |
| 08/12/2009 | CN101502562A Medicament composition for protecting and promoting regeneration function of hepatocyte and preparation method |
| 08/12/2009 | CN101502560A External-use Chinese medicinal composition for treating odontopathy |
| 08/12/2009 | CN101502551A Synergistic composition containing bifendate |
| 08/12/2009 | CN101502545A Method for preparing Chinese medicine for resisting cancer and treating cancer ache |
| 08/12/2009 | CN101502536A Cedar total flavone as well as preparation method and medical use |
| 08/12/2009 | CN101502533A Novel hydrocarbonate dialysis powder |
| 08/12/2009 | CN101502532A Application of triple spiral Dictyophora phalloidea polysaccharide |
| 08/12/2009 | CN101502531A 3'-or 2'-hydroxymethyl substituted nucleoside derivatives for treatment of hepatites virus infections |
| 08/12/2009 | CN101502530A Medicament composition containing ginseng saponin and periplocin and uses thereof |
| 08/12/2009 | CN101502529A Application of vincetoxicoside B in preparing antidiabetic medicament |
| 08/12/2009 | CN101502528A Application of esculentoside A in preparing medicament for preventing or treating pulmonary fibrosis |
| 08/12/2009 | CN101502527A Application of mulberroside in preparing medicament for inhibiting uric acid reabsorption transporter |
| 08/12/2009 | CN101502526A Application of mulberry twig flavone and diphenyl ethylene extract in preventing or treating hyperuricemia symptoms and uarthritis |
| 08/12/2009 | CN101502525A Application of low-polyxylose in preparing product for preventing and treating colpitis |
| 08/12/2009 | CN101502524A Application of acetyl-fluorobenzene salicylamide compound in preparing anti-tumor medicament |
| 08/12/2009 | CN101502523A Application of benzoyl fluorobenzene salicylamide compound in preparing anti-tumor medicament |
| 08/12/2009 | CN101502522A Acyclovir enteric sustained-release preparation composition and method for preparing the same |
| 08/12/2009 | CN101502521A Acyclovir sustained-release preparation composition and method for preparing the same |
| 08/12/2009 | CN101502520A Acyclovir enteric-coated formulation composition and method for preparing the same |
| 08/12/2009 | CN101502519A Novel use of vitamin B6 and folic acid namely effects of the two medicaments used together for tranquilizing, hypnotizing and strengthening abirritation |
| 08/12/2009 | CN101502518A Glipizide sustained-release granular formulation and preparation method thereof |
| 08/12/2009 | CN101502517A Glipizide enteric sustained-release preparation composition and method for preparing the same |
| 08/12/2009 | CN101502516A Glipizide enteric-coated formulation composition and method for preparing the same |
| 08/12/2009 | CN101502515A Hydrochloride loratadine enteric-coated formulation composition and method for preparing the same |
| 08/12/2009 | CN101502514A Rifaximin enteric sustained-release preparation composition and method for preparing the same |
| 08/12/2009 | CN101502513A Rifaximin sustained-release preparation composition and method for preparing the same |
| 08/12/2009 | CN101502512A Amoxicillin/clavulanic acid blended stock preparation and rapid determination method for evenness |
| 08/12/2009 | CN101502511A Amoxicillin/clavulanate potassium tablet and preparation method thereof |